Is there a role for diacylglycerol kinase-zeta in cell cycle regulation?
Is there a role for diacylglycerol kinase-zeta in cell cycle regulation?
The retinoblastoma tumor suppressor protein (pRB) and its close relatives p107 and p130 aremaster switches in the regulation of developmental processes, including cell cycle regulation,differentiation and apoptosis (Chau and Wang, 2003; Cobrinik, 2005; Nguyen and McCance,2005). During the cell cycle, pRB regulates the G1 to S-phase transition by binding to and inhibiting the activity of the E2F family of transcription factors (Seville et al., 2005). Under optimal conditions for cell division cyclin-dependent kinases (CDKs EC 2.7.11.22)phosphorylate pRB during G1 of the cell cycle, which liberates E2F from its complex withpRB. E2F can then regulate the transcription of genes required for G1eS phase progression.Phosphorylation of pRB in G1 is carried out by cyclin D in complex with CDK4 or CDK6,and cyclin EeCDK2 (Sherr and Roberts, 2004). CyclineCDK complexes, in turn, are regulatedby CDK inhibitors (CKIs). The CIP/KIP family of CKIs, including p21WAF1/CIP1, p27KIP1 andp57KIP2, inhibit cyclin EeCDK complexes, whereas they stabilize and activate cyclin DeCDK4/6 complexes. The INK family of CKIs, including p16INK4a, p15INK4b, p18INK4c andp19INK4d, specifically inhibit CDK4/6 (Sherr and Roberts, 1999). Under several conditions thephosphorylation of pRB is inhibited, enabling the interaction between pRB and E2F and the induction of a G1-arrest. These conditions include depletion of growth factors (Sherr and Roberts,1999), growth inhibitory signals from the TGFb super family, contact inhibition (Li et al., 1995;
Animals Cell Cycle/drug effects/*physiology Cell Line Cell Line, Tumor Diacylglycerol Kinase/*physiology G1 Phase/drug effects Humans Mice Osteosarcoma/metabolism Retinoblastoma Protein/metabolism Swiss 3T3 Cells
31-39
Los, A. P.
b18f6574-eabc-42b9-8078-026cbc47d487
de Widt, J.
8e144c94-ffc7-47c5-afe9-1dc463c3621f
van Blitterswijk, W. J.
aa501394-3d66-4738-9483-b025ce31b3c7
Divecha, N.
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
2008
Los, A. P.
b18f6574-eabc-42b9-8078-026cbc47d487
de Widt, J.
8e144c94-ffc7-47c5-afe9-1dc463c3621f
van Blitterswijk, W. J.
aa501394-3d66-4738-9483-b025ce31b3c7
Divecha, N.
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
Los, A. P., de Widt, J., van Blitterswijk, W. J. and Divecha, N.
(2008)
Is there a role for diacylglycerol kinase-zeta in cell cycle regulation?
Advances in Enzyme Regulation, 48 (1), .
(doi:10.1016/j.advenzreg.2008.02.001).
Abstract
The retinoblastoma tumor suppressor protein (pRB) and its close relatives p107 and p130 aremaster switches in the regulation of developmental processes, including cell cycle regulation,differentiation and apoptosis (Chau and Wang, 2003; Cobrinik, 2005; Nguyen and McCance,2005). During the cell cycle, pRB regulates the G1 to S-phase transition by binding to and inhibiting the activity of the E2F family of transcription factors (Seville et al., 2005). Under optimal conditions for cell division cyclin-dependent kinases (CDKs EC 2.7.11.22)phosphorylate pRB during G1 of the cell cycle, which liberates E2F from its complex withpRB. E2F can then regulate the transcription of genes required for G1eS phase progression.Phosphorylation of pRB in G1 is carried out by cyclin D in complex with CDK4 or CDK6,and cyclin EeCDK2 (Sherr and Roberts, 2004). CyclineCDK complexes, in turn, are regulatedby CDK inhibitors (CKIs). The CIP/KIP family of CKIs, including p21WAF1/CIP1, p27KIP1 andp57KIP2, inhibit cyclin EeCDK complexes, whereas they stabilize and activate cyclin DeCDK4/6 complexes. The INK family of CKIs, including p16INK4a, p15INK4b, p18INK4c andp19INK4d, specifically inhibit CDK4/6 (Sherr and Roberts, 1999). Under several conditions thephosphorylation of pRB is inhibited, enabling the interaction between pRB and E2F and the induction of a G1-arrest. These conditions include depletion of growth factors (Sherr and Roberts,1999), growth inhibitory signals from the TGFb super family, contact inhibition (Li et al., 1995;
This record has no associated files available for download.
More information
Accepted/In Press date: 13 February 2008
Published date: 2008
Additional Information:
Los, Alrik P de Widt, John van Blitterswijk, Wim J Divecha, Nullin eng Research Support, Non-U.S. Gov't England 2008/03/25 Adv Enzyme Regul. 2008;48:31-9. doi: 10.1016/j.advenzreg.2008.02.001. Epub 2008 Feb 13.
Keywords:
Animals Cell Cycle/drug effects/*physiology Cell Line Cell Line, Tumor Diacylglycerol Kinase/*physiology G1 Phase/drug effects Humans Mice Osteosarcoma/metabolism Retinoblastoma Protein/metabolism Swiss 3T3 Cells
Identifiers
Local EPrints ID: 480163
URI: http://eprints.soton.ac.uk/id/eprint/480163
ISSN: 1873-2437
PURE UUID: 43040d2e-9585-44f0-ad30-f6e2fff54527
Catalogue record
Date deposited: 01 Aug 2023 16:56
Last modified: 17 Mar 2024 02:59
Export record
Altmetrics
Contributors
Author:
A. P. Los
Author:
J. de Widt
Author:
W. J. van Blitterswijk
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics